chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Friday: Nothing the day of. Saturday: The next day, chills on and off throughout the day starting in the early afternoon. fatigue. Sunday: The following day, chills, very low fever, fatigue, slight ache of muscles, coughing with a tickle in throat, shortness of breath (feeling I couldn't take a full deep breath). Monday: Felt almost completely back to normal, with just a slight tickle in the throat lingering. Tuesday: 100% back to normal.
Pt recv vax on 2/17/99; within 1 hr post vax pt exp rash on arms, chest, back & abdomen; tx=Benadryl
grand mal sz p/receiving DPT/HEP B/PPD/MMR vax on 26APR in clinic
We had five ped patients that received the PENTACEL . Out of the 5 patients one patient didn't receive the reconstitute ACTHIB.
Interchange of Vaccine products; testing positive for COVID; testing positive for COVID; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 59 years for covid-19 immunisation; BNT162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: EL3248), on 12Feb2021 as dose 2, single (Lot number: EL9269) and on 22Aug2022 as dose 4 (booster), single (Lot number: FM533) for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 23Nov2021 as dose 3 (booster), single (Lot number: 039F21A) for covid-19 immunisation. The patient's relevant medical history included: "Alpha-1 antitrypsin deficiency, hypercholesterolemia, hypertension" (unspecified if ongoing); "Known allergies Bee stings" (unspecified if ongoing); "hypercholesterolemia" (unspecified if ongoing); "hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 22Nov2022, outcome "unknown" and all described as "testing positive for COVID"; INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22Nov2022) Positive; (30Nov2022) Negative, notes: I improved and tested negative on 30Nov2022. Therapeutic measures were taken as a result of vaccination failure, covid-19 for which included PF-07321332, ritonavir (PAXLOVID) from 22Nov2022 to 26Nov2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On an unknown date, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # and expiry date were unknown) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a physician and from a support services director and refers to a patient of unknown age and gender. No information regarding the patient's medical history and concurrent conditions was provided. On 04-JUN-2014, the patient was vaccinated with an improperly stored dose PNEUMOVAX 23 injection (lot # J011042, expiry date: 04-MAR-2015; exact dose and route of administration were not reported). There were no concomitant therapies reported. On an unknown date, the dose of the vaccine was exposed to the temperature excursion lasting 696 hours with the lowest recorded temperature of 20 degrees Fahrenheit (-6.66 degrees Celsius). The vaccine was stored in a refrigerator. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Headaches for 3-4 days following and chest tightness for 3-4 days following
headache; fatigue; chills; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 62 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 17Mar2021 12:00 (Lot number: EN6202, Expiration Date: 30Jun2021) at the age of 62 years as dose 2, single for covid-19 immunization. Relevant medical history included: "Seasonal allergies" (ongoing), notes: Onset date: Ongoing (+35 yrs); "Pneumonia", start date: Feb2020, stop date: Mar2020; "Bronchitis", start date: Oct2019, stop date: Nov2019. The patient's concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Batch/Lot Number: EN6202, Expires 30Jun2021, Anatomical Site of Injection: Left Arm, Time:12:00 PM), administration date: 24Feb2021, when the patient was 62 years old, for covid-19 immunization, reaction: "Headache"; Allergy serum (Anatomical Site of injection: Both Arms (2- L arm, 1- other) 3 shots total), administration date: 10Feb2021; Allergy serum (Anatomical Site of injection: Both Arms (2- L arm, 1- other) 3 shots total), administration date: 03Mar2021. The following information was reported: HEADACHE (non-serious) with onset 17Mar2021 21:00, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious) with onset 17Mar2021 21:00, outcome "recovered" (2021), described as "fatigue"; CHILLS (non-serious) with onset 17Mar2021 21:00, outcome "recovered" (2021), described as "chills". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, fatigue and chills.  Additional information: Treatment received were Tylenol and rest.  No follow-up attempts are possible. No further information is expected.
Sore throat, fatigue, and runny nose -- not terrible, but wasn't expecting the sore throat, and thought I should report..
Early menstrual period onset 11 days after receiving the first dose of the Moderna Covid 19 vaccine. Period arrived 9 days earlier than scheduled with no recent history of irregularity in cycle.  Two days prior to period onset I experienced very tender breasts and cramping.
Patient c/o not feeling well, was shaky, nauseous with HA.  Once she got home 30 minutes later she ate dinner and threw-up, c/o headache and was sweaty.  Next morning c/o severe headache that lasted throughout day.  Today still has headache.  Encouraged Mom to give daughter Ibuprofen or Tylenol and have her drink plenty of water.
Face started tingling then a numb sensation - much like how novacaine feels. Face swelled next day, still tingling/numb sensation.  Ears itchy.  Called primary care provider was advised to take Benadryl. Took Benadryl  for one day. Facial swelling went away but tingling/numbness is still occurring with occasional itchiness.
felt that she was not at peak performance; feeling physically worn out/physically tired; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PERFORMANCE STATUS DECREASED (felt that she was not at peak performance), VACCINATION SITE PAIN (sore arm) and FATIGUE (feeling physically worn out/physically tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001BZIA) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 15-Mar-2021, the patient experienced PERFORMANCE STATUS DECREASED (felt that she was not at peak performance) and FATIGUE (feeling physically worn out/physically tired). At the time of the report, PERFORMANCE STATUS DECREASED (felt that she was not at peak performance), VACCINATION SITE PAIN (sore arm) and FATIGUE (feeling physically worn out/physically tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medication was provided
Right upper arm redness, warmth, itchiness, pain 8/10 x 2 days. Redness progressively spread down to elbow area.
Muscle Aches; Chills; Pain at site; Redness/ redness at insertion site; itching at the insertion site; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th January 2020, the patient received the 2nd dose of Shingrix. In January 2020, less than a week after receiving Shingrix, the patient experienced muscle pain, chills, injection site pain, injection site erythema and injection site itching. On an unknown date, the outcome of the muscle pain, chills and injection site pain were recovered/resolved and the outcome of the injection site erythema and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, chills, injection site pain, injection site erythema and injection site itching to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported but it could be 65 or 66 years old. The reporter stated that the patient had muscle pain, chills and injection site pain after vaccination. The patient also had redness and itching at insertion site. The reporter asked about the pathology that causes side effects with the second shot. The reporter did not consent to follow up. This case is 1 out of 3 cases reported by the same reporter
Narrative: COVID infections following completion of COVID vaccine series 04/02/21 COVID vaccine dose #1 04/23/21 COVID vaccine dose #2 07/30/21 Pt presents for preop COVID test with no symptoms; COVID POSITIVE 07/31/21 Pt remains asymptomatic
The patient had pressure pain above elbow then moved to forearm (pain scale 3-4). Then patient moved to a dull ache, pinpoint above wrist with patient scale of 1.
PT. FELL TO GROUND AFTER EXITING CLINIC, HITTING BACK OF HEAD. TWO NURSES IMMEDIATELY ARRIVED OUTSIDE CLINIC TO  PT. SHE WAS IN FULL BODY TREMORS LASTING < 60 SEC. PT AWOKE AND ASKED WHAT HAPPENED.  COMFORT MEASURES PROVIDED WHILE AWAITING EMS. TRANSPORTED BY EMS TO LOCAL ER.
This spontaneous report as received from a healthcare worker (medical assistant) refers to a 14 year old patient of unknown gender. The patient had received the first dose of (Oka/Merck) VARIVAX before. The healthcare worker confirmed that ZOSTAVAX was mistakenly shipped to this office instead of (Oka/Merck) VARIVAX. On an unknown date the patient was then inadvertently vaccinated with a dose of ZOSTAVAX (dose, route not reported, lot # K007986, expiration date 03-SEP-2015) instead of (Oka/Merck) VARIVAX, "within this past week", in approximately in September 2014. Concomitant medications were not provided. No adverse effects were reported. This is one of eight reports received from the same reporter. Additional information has been requested.
Hideous reaction. Unsafe vaccine most likely destroyed child's health and life. Should be recalled by CDC. Irresponsible and unsafe to give this to baby. 104 fever (6/25/03), shaking, glazed eyes. Total lethargy. 6/26 105 fever, high fever 8 days. Rash on entire body even scalp, exhaustion 8 days. Never the same again. Lost all speech, glazed eyes - spaced out look. Lost eye contact, became autistic. 7/1 still sick. 103 fever 8 days.12/14/07-records received for DOS 5/20/02-6/20/05-include well and sick visits.Fever times 2 days, cold symptoms with frequent stools on 9/29/02-Congested, fever vomited on 1/12/03-. Vomiting and increased fatigue on 2/13/03. Achieving milestones 6/20/03. Fever vomiting and shaking 6/26/03. Drooling, fever runny nose congested 10/14/03-upper respiratory infection.
following day p/vax student devel fever 103.5 & generally didn't feel well;
This is a spontaneous report from a contactable other HCP. This 28-year-old female other HCP reported for herself that she received bnt162b2 (BNT162B2, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in arm right on 19Feb2021 09:45 (Batch/Lot Number: EL9266) as SINGLE DOSE for covid-19 immunization. Medical history included, hashimoto's, mitral valve prolapse, known allergy, gluten. The patient's concomitant medications were not reported. The patient previously took bnt162b2 for covid-19 immunization (dose number 1, Lot number: EL3247), erythromycin and experienced known allergy: erythromycin. It was reported that, the 11 days (02Mar2021) after she received her second vaccine, she broke out in a full body rash/hives starting around 2:30pm. The rash was around my eyes, chin, ears, arms, armpits, hands, torso, shoulders, back, legs, and thighs. She took benadryl immediately (took one dose at 2:30pm and another dose at 6:30pm). The rash lasted the rest of the day and when she woke up the next morning it was gone. Later that day (03Mar2021), the rash/raised hives came back around 10:30am on my legs, back, right arm, neck, and buttocks. She took Benadryl and prescription steroids again and the rash lasted the rest of the day. The following morning (04Mar201) the rash was gone and has not come back as of today (05Mar2021). The outcome of the events was unknown.No follow-up attempts are possible; information about lot/batch number cannot been obtained.
"I had little bit of a  Headache the first day.Then I noticed a  swollen area, like a red swollen bump, below where I got my shot in my left arm; Her arm is red; It also feels like the caller was punched under her arms and in her chest, its very tender; Caller states that yesterday was worse with nausea and no vomiting; I had little bit of a Headache the first day.Then I noticed a  swollen area, like a red swollen bump, below where I got my shot in my left arm; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0175), via an unspecified route of administration in left arm on 27Apr2021 (at the age of 55-year-old) as dose 2, single for COVID-19 immunization. Medical history included thyroid cancer from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Previously patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: ER8737), via an unspecified route of administration in arm left on 06Apr2021 (at the age of 55-year-old) as dose 1, single for COVID-19 immunization. On 27Apr2021, the patient had little bit of a headache the first day. On 29Apr2021, then noticed a swollen area, like a red swollen bump, below where she got her shot in her left arm, very tender under both arms, more so under her left arm. The patient reported that her arm is red and swollen below the shot site, like a big goose egg. It also feels like she was punched under her arms and in her chest, its very tender. The caller thought it was weird that this showed up so late after receiving the vaccine. Patient states that on 29Apr2021 was worse with nausea and no vomiting. The caller's blood pressure was taken in her left arm on 29Apr2021 and then the goose egg appeared. The patient wanted to know whether she can take some benedryl and something for the pain or do she just need to ride it out. The outcome of headache, nausea was reported as unknown and swollen arm, erythema, tenderness was not resolved.  No follow-up attempts are needed. No further information is expected.
about an hour have receiving the injection i experienced a mild rash from armpit to armpit. I do have sensitive skin and was doing yard work earlier in the day so that may be the cause. It only last a few hours.
Left side neck pain that subsided on it own . negative weakness numbness and /or tingling  and had full ROM
panic attack 2 hours after vaccine; since, multiple panic attacks, with other episodes of feeling like i'm going to pass out, dizzy, nauseated, tachycardic
pt recv vax 1JUN98 & 11JUN98 pt devel a rash all over body, a fever & petechiae;14JUN97 pt was taken to an ER & adm to hosp platelets were 120,000 in ER & dropped to 107,000 the following day;
Pt received H1N1 vaccine yesterday. C/O tenderness to site, weakness, fatigue, body aches, fever and chills 4 hours post vaccine. PS she's taking ADVIL and feels better.
Patient stated that her arm was hurting.  She was observed to have a hot, red, hard, and swollen left side of her shoulder where the vaccine administration occurred.
Pt vax w/DTP/IPV developed fever to 102 approx 12 hrs /p shot. Seen next day temp 99(ax). 3.5cm erythema, induration at inject site.
Information has been received from a registered nurse concerning a 13 month old female with alot of allergies who on 07/14/2004 was vaccinated with a dose of varicella virus vaccine live.  Concomitant therapy included montelukast sodium, albuterol, lansorprazole and fluticasone propionate.  On 07/17/2004 the patient experienced breakthrough case of varicella.  She developed 5 pox; one at the back of her neck, one back of her hand, two on her forehead, one on her ankle and one on her arm.  The patient also developed large swelling at the vaccination site which disappeared one to two hours later.  On 07/18/2004 the patient was seen by the physician.  Two weeks later at the site of injection, a lump appeared which does not seem to bother the patient.  The patient's pox have since scabbed over and are gone, but the injections site lump has lingered for two weeks.  It was also reported that the swelling lingers.  The patient had no known exposure to varicella.  There was no product quality complaint involved.  The reporter indicated that two other patients had similar experiences following exposure to varicella virus vaccine live.  Additional information has been requested.
Headache, Myalgia, CoughWheeze, Diarrhea, Nausea Vomiting,  Sore throat, fatigue  Narrative:
Information has been received from a registered nurse concerning a 63 year old white female with diabetes mellitus and allergies to codeine and IPV dye who on 10/23/02 was vaccinated with a second dose of pneumococcal vaccine 23 polyvalent in the right deltoid (lot 642749/0111M). On 10/25/02, the pt developed an area of redness at injection site that was hot from the top of arm to elbow. The pt was unable to move her arm. She also developed a fever, nausea and a headache. The pt was treated with Medrol.  It was reported the pt had a severe headache and her face was flushed from the methylprednisolone which stopped after 2-3 days. Additional info was received from the nurse and an ER report. The nurse reported that on 10/23/02, the pt's right arm was red and swollen. On 10/25/02, the pt contacted the office and reported that the pt's arm was swollen, red, and painful. The pt was told to go to the ER. The ER report indicated that in the ER, the pt denied any fever or chills. On the left arm, there was an area of erythema measuring 10cm x 8cm of the left arm. There was swelling with pain on movement of the left arm. The pt had an IV established and was given Rocephin 1g. It was reported that the pt did receive a flu shot on 10/23/02. The pt's symptoms were thought to be a localized reaction versus early cellulitis. The pt was treated for presumed early cellulitis and sent home. The nurse reported that the primary care nurses in the practice always administer the pneumococcal vaccine in the right arm and the influenza vaccine in the left arm. She stated that she thought the documentation from the ER report was incorrect and should have read "in the right arm." On 10/26/02, the pt returned to the ER for follow-up. On physical examination, the cellulitis had receded from the outer margins of the previous day's visit. The pt stated that she was feeling somewhat better; however, she did continue to have mild pain in the left arm. The pt had no fever. The pt had an IV established and was given ceftriaxone 2mg IV. The pt was started on therapy with Duricef and was sent home. The nurse indicated that she followed up with the pt, and she had subsequently recovered. Upon internal review, the pt's cellulitis was considered an other medical event (OMIC). The nurse also reported that a pt developed injection site swelling, inflammation, erythema, pain and drug hypersensitivity (WAES0210USA02661) and another pt developed injection site erythema and inflammation (WAES0210USA02662) post-vaccination with pneumococcal vaccine 23 polyvalent. No additional info is expected.
laughing, talking & eating well 2NOV92; 3NOV92 wake & vomited BP 180/110, P 100; 550 became listless, BP 75/50,  P diff to count; twitching
Received flu vaccine 11/2/2010 and began wheezing about 2 hours later. He went to hospital ER. Discharge diagnosis - URI and Allergic Reaction.
Patient had a syncope episode and was unresponsive. Patient had decreased oxygen saturation and pulse with blood pressure remaining stable. EMT called and patient transferred to medical center.
patient states has history of food reactions with itchiness, scratching of throat, within 15 minutes complained of scratching of throat, able to drink water, spoke normally, O2 sats 97% , Respirations 18, sat in observation for thirty minutes drinking water , talking and laughing, then was offered to go to urgent care but patient refused
Erythematous vesicopustules appeared at the site of vaccine administration the day after presentation. A few bumps on chin as well but with different appearance, more like drool rash. Doesn't have illness symptoms to suggest viral illness, but could be possible. Rash not bothersome to patient. Advised parent to monitor site and try antihistamine.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 25-MAR-2014, the patient was vaccinated with an improperly stored dose of GARDASIL (lot # J006236, expiration date: 25-FEB-2016) dose and route were not reported. No adverse experiences were reported. This is one of several reports received from the same source. Additional information has been requested.
Pt received varicella vaccine 9/6/12. On 9/14/12 she developed a rash with just a few spots and it has spread to her whole body - itchy with low grade fever.
A MRI was done on my left breast on 7/21/21.  The results showed an enlarged lymph node in the left axilla.  An ultrasound was done to confirm it.  Probably benign.  I will go back for another ultrasound in 6 months.
Pt and mother instructed to wait 15mins after vaccines. About 3 mins later, Patient fainted with sudden loss of consciousness with jaw tightness lasting 30 sec. Pt regained consciousness with neuro intact. A&O X4. No fall, no loss of bowel or bladder, no jerking movement or stiffness.  Pt tolerated water and decline blood glucose checkup, and vomited after and stated, "he felt better". EMS was called, V/S was stable at b/p 116/68, hr -70, rr-18. Pt declined going to the ER.  Pt and mother instructed to go to the ER with any seizure activities, loss of consciousness. Pt and mother verbalized understanding
Shortness of breath, fever, 1st flu shot. Chills, went to bed early 2 PM and slept long time (15 hours).